Oseltamivir Market Share

Statistics for the 2023 & 2024 Oseltamivir market share, created by Mordor Intelligence™ Industry Reports. Oseltamivir share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Oseltamivir Industry

The oseltamivir market is fragmented and competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market, which include F. Hoffmann-La Roche Ltd, Cipla Inc., Zydus Cadila, NATCO Pharma Limited, Macleods Pharmaceuticals Ltd, Amneal Pharmaceuticals LLC, and Alembic Pharmaceuticals Limited.

Oseltamivir Market Leaders

  1. F. Hoffmann-La Roche Ltd

  2. Cipla Inc

  3. Zydus Cadila

  4. NATCO Pharma Limited

  5. Macleods Pharmaceuticals Ltd

*Disclaimer: Major Players sorted in no particular order

Picture2.png

Oseltamivir Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)